首页> 外国专利> New fusion protein including the leptin receptor, useful in screening compounds for treating leptin-related disorders, also contains an energy donating or accepting protein

New fusion protein including the leptin receptor, useful in screening compounds for treating leptin-related disorders, also contains an energy donating or accepting protein

机译:包括瘦素受体在内的新融合蛋白可用于筛选治疗瘦素相关疾病的化合物,还含有一种供能或接受能量的蛋白

摘要

Fusion protein (FP) that comprises: (a) a leptin receptor (LR), having a short intracellular domain; a soluble form of LR containing a leptin-binding sequence, or a substantial part of such a receptor; and (b) a protein (I) that is an energy donor or acceptor, or a substantial, active part of it, is new. Independent claims are also included for the following: (1) nucleic acid (II) that encodes FP; (2) nucleic acid (IIa) that is at least 65% identical with (II) or hybridizes to (II) under stringent conditions; (3) cells, or their fragments, lysates and membranes, that contain (II) or (IIa), or express FP; (4) composition containing the cells of (3) and a saponin; (5) determining binding of compounds to LR; (6) screening or detecting compounds suitable for preventing or treating leptin-associated diseases; and (7) screening for agonists and antagonists of LR.
机译:融合蛋白(FP),其包含:(a)具有短细胞内结构域的瘦蛋白受体(LR);含有瘦蛋白结合序列的LR的可溶形式,或这种受体的主要部分; (b)作为能量供体或受体或其实质性活性部分的蛋白质(I)是新的。还包括以下方面的独立权利要求:(1)编码FP的核酸(II); (2)在严格条件下与(II)具有至少65%同一性或与(II)杂交的核酸(IIa); (3)含有(II)或(IIa)或表达FP的细胞或其片段,裂解物和膜; (4)含有(3)的细胞和皂苷的组合物。 (5)确定化合物与LR的结合; (6)筛选或检测适合于预防或治疗瘦素相关疾病的化合物; (7)筛选LR的激动剂和拮抗剂。

著录项

  • 公开/公告号NO20043503L

    专利类型

  • 公开/公告日2004-08-23

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMA SA;

    申请/专利号NO20040003503

  • 发明设计人 JOCKERS RALPH;COUTURIER CYRIL;

    申请日2004-08-23

  • 分类号C07K19/00;C07K14/705;C12N15/62;G01N33/566;

  • 国家 NO

  • 入库时间 2022-08-21 23:09:30

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号